Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegbelfermin in Obese Adults With Type 2 Diabetes
NCT02097277Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Apr 2014
- Primary completion
- Sep 2015
- Modality
- Cytokines & Interferons
- Countries
- 2
01
Overview
A Phase 2 trial of pegbelfermin in type 2 diabetes mellitus (T2DM), obesity, sponsored by Bristol Myers Squibb. Started Apr 2014; status: completed.
02
Drugs
pegbelfermin
03
Conditions
type 2 diabetes mellitus (T2DM)obesity
Beyond the preview
Go deeper on NCT02097277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02097277.